Ullem Scott B. 4

What Happened

• Scott B. Ullem, Chief Financial Officer of Edwards Lifesciences (EW), disposed of 199 shares on Feb 16, 2026 to satisfy a tax obligation tied to an equity transaction. The shares were valued at $75.87 each, for a total of $15,098. This transaction was recorded as a share withholding/payment of tax liability (transaction code F), not an open-market sale.

Key Details

• Transaction date & price: 199 shares at $75.87 on 2026-02-16.
• Total value of shares disposed: $15,098.
• Transaction code: F (payment of exercise price or tax liability / share withholding).
• Shares owned after the transaction: Not specified in the Form 4 filing.
• Filing timeliness: Report filed 2026-02-17 for a 2026-02-16 transaction (filed promptly).
• Filing remark: The Form 4 notes it reflects changes in beneficial ownership only and may not list other securities held by the reporting person.

Context

• This was a tax-withholding/settlement action (shares surrendered to cover taxes), which is a routine administrative disposal and not the same as an open-market sale signaling a change in sentiment.
• For options or restricted stock events, companies commonly withhold or surrender shares to cover taxes; such transactions typically do not change the executive’s overall economic exposure in the same way a planned sale would.